Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:caused_by |
avian influenza
|
| gptkbp:clinical_trial |
antiviral drugs
H5 N1 vaccines |
| gptkbp:collaborations |
gptkb:WHO_collaboration
FAO involvement OIE involvement |
| gptkbp:controls |
public awareness campaigns
monitoring bird populations culling infected birds |
| gptkbp:cultivation |
trade restrictions
food security concerns poultry industry losses |
| gptkbp:distribution |
gptkb:Africa
gptkb:Europe gptkb:Middle_East gptkb:Asia |
| gptkbp:end_of_life |
60% in humans
|
| gptkbp:future_plans |
public health preparedness
emergence of new strains vaccine mismatch risks |
| gptkbp:genetic_diversity |
phylogenetic analysis
viral evolution potential for human-to-human transmission |
| gptkbp:healthcare |
health education programs
vaccination campaigns pandemic potential |
| https://www.w3.org/2000/01/rdf-schema#label |
H5 N1 virus
|
| gptkbp:is_monitored_by |
global health organizations
|
| gptkbp:is_protected_by |
biosecurity measures
vaccination of poultry |
| gptkbp:is_recognized_by |
gptkb:1997
|
| gptkbp:is_vulnerable_to |
H5 N1 vaccine
|
| gptkbp:notable_species |
gptkb:nebula
wild birds chickens geese turkeys pigeons domestic ducks |
| gptkbp:regulatory_compliance |
import/export restrictions
avian influenza surveillance programs |
| gptkbp:research |
vaccine development
antiviral resistance |
| gptkbp:reservoir |
wild birds
|
| gptkbp:responds_to |
emergency preparedness
|
| gptkbp:risk_factor |
poultry workers
|
| gptkbp:social_responsibility |
gptkb:zoo
2003-2004 2006-2007 2014-2015 serological tests PCR testing |
| gptkbp:symptoms |
cough
fever sore throat difficulty breathing muscle aches |
| gptkbp:transmission |
bird to human
|
| gptkbp:treatment |
antiviral medications
|
| gptkbp:bfsParent |
gptkb:neuraminidase
|
| gptkbp:bfsLayer |
7
|